CD8A and neoplasm: MFC tumor-bearing mice models were established, and mice were assigned to the following treatment groups: Control, Asparaginase + anti-PD-L1, Asparaginase + anti-PD-L1 + anti-CD4, and Asparaginase + anti-PD-L1 + anti-CD8.